Global Nanomedicines Market Research Report 2022

SKU ID : QYR-21213016 | Publishing Date : 05-Jul-2022 | No. of pages : 89

Detailed TOC of Global Nanomedicines Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nanomedicines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Nanoparticles
        1.2.3 Nanoshells
        1.2.4 Nanotubes
        1.2.5 Nanodevices
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Nanomedicines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Institute
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Nanomedicines Market Perspective (2017-2028)
    2.2 Nanomedicines Growth Trends by Region
        2.2.1 Nanomedicines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Nanomedicines Historic Market Size by Region (2017-2022)
        2.2.3 Nanomedicines Forecasted Market Size by Region (2023-2028)
    2.3 Nanomedicines Market Dynamics
        2.3.1 Nanomedicines Industry Trends
        2.3.2 Nanomedicines Market Drivers
        2.3.3 Nanomedicines Market Challenges
        2.3.4 Nanomedicines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Nanomedicines Players by Revenue
        3.1.1 Global Top Nanomedicines Players by Revenue (2017-2022)
        3.1.2 Global Nanomedicines Revenue Market Share by Players (2017-2022)
    3.2 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Nanomedicines Revenue
    3.4 Global Nanomedicines Market Concentration Ratio
        3.4.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2021
    3.5 Nanomedicines Key Players Head office and Area Served
    3.6 Key Players Nanomedicines Product Solution and Service
    3.7 Date of Enter into Nanomedicines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicines Breakdown Data by Type
    4.1 Global Nanomedicines Historic Market Size by Type (2017-2022)
    4.2 Global Nanomedicines Forecasted Market Size by Type (2023-2028)
5 Nanomedicines Breakdown Data by Application
    5.1 Global Nanomedicines Historic Market Size by Application (2017-2022)
    5.2 Global Nanomedicines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Nanomedicines Market Size (2017-2028)
    6.2 North America Nanomedicines Market Size by Country (2017-2022)
    6.3 North America Nanomedicines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Nanomedicines Market Size (2017-2028)
    7.2 Europe Nanomedicines Market Size by Country (2017-2022)
    7.3 Europe Nanomedicines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Nanomedicines Market Size (2017-2028)
    8.2 Asia-Pacific Nanomedicines Market Size by Country (2017-2022)
    8.3 Asia-Pacific Nanomedicines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Nanomedicines Market Size (2017-2028)
    9.2 Latin America Nanomedicines Market Size by Country (2017-2022)
    9.3 Latin America Nanomedicines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Nanomedicines Market Size (2017-2028)
    10.2 Middle East & Africa Nanomedicines Market Size by Country (2017-2022)
    10.3 Middle East & Africa Nanomedicines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Nanomedicines Introduction
        11.1.4 Abbott Revenue in Nanomedicines Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 GE Healthcare
        11.2.1 GE Healthcare Company Detail
        11.2.2 GE Healthcare Business Overview
        11.2.3 GE Healthcare Nanomedicines Introduction
        11.2.4 GE Healthcare Revenue in Nanomedicines Business (2017-2022)
        11.2.5 GE Healthcare Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Nanomedicines Introduction
        11.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Nanomedicines Introduction
        11.4.4 Merck Revenue in Nanomedicines Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Nanomedicines Introduction
        11.5.4 Pfizer Revenue in Nanomedicines Business (2017-2022)
        11.5.5 Pfizer Recent Development
    11.6 CombiMatrix
        11.6.1 CombiMatrix Company Detail
        11.6.2 CombiMatrix Business Overview
        11.6.3 CombiMatrix Nanomedicines Introduction
        11.6.4 CombiMatrix Revenue in Nanomedicines Business (2017-2022)
        11.6.5 CombiMatrix Recent Development
    11.7 Celgene
        11.7.1 Celgene Company Detail
        11.7.2 Celgene Business Overview
        11.7.3 Celgene Nanomedicines Introduction
        11.7.4 Celgene Revenue in Nanomedicines Business (2017-2022)
        11.7.5 Celgene Recent Development
    11.8 Mallinckrodt
        11.8.1 Mallinckrodt Company Detail
        11.8.2 Mallinckrodt Business Overview
        11.8.3 Mallinckrodt Nanomedicines Introduction
        11.8.4 Mallinckrodt Revenue in Nanomedicines Business (2017-2022)
        11.8.5 Mallinckrodt Recent Development
    11.9 Sigma-Tau Pharmaceuticals
        11.9.1 Sigma-Tau Pharmaceuticals Company Detail
        11.9.2 Sigma-Tau Pharmaceuticals Business Overview
        11.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
        11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2022)
        11.9.5 Sigma-Tau Pharmaceuticals Recent Development
    11.10 Teva Pharmaceutical
        11.10.1 Teva Pharmaceutical Company Detail
        11.10.2 Teva Pharmaceutical Business Overview
        11.10.3 Teva Pharmaceutical Nanomedicines Introduction
        11.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2022)
        11.10.5 Teva Pharmaceutical Recent Development
    11.11 Nanosphere
        11.11.1 Nanosphere Company Detail
        11.11.2 Nanosphere Business Overview
        11.11.3 Nanosphere Nanomedicines Introduction
        11.11.4 Nanosphere Revenue in Nanomedicines Business (2017-2022)
        11.11.5 Nanosphere Recent Development
    11.12 UCB SA
        11.12.1 UCB SA Company Detail
        11.12.2 UCB SA Business Overview
        11.12.3 UCB SA Nanomedicines Introduction
        11.12.4 UCB SA Revenue in Nanomedicines Business (2017-2022)
        11.12.5 UCB SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Nanomedicines Market Research Report 2022

List of Tables
    Table 1. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Nanoparticles
    Table 3. Key Players of Nanoshells
    Table 4. Key Players of Nanotubes
    Table 5. Key Players of Nanodevices
    Table 6. Key Players of Others
    Table 7. Global Nanomedicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Nanomedicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Nanomedicines Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Nanomedicines Market Share by Region (2017-2022)
    Table 11. Global Nanomedicines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Nanomedicines Market Share by Region (2023-2028)
    Table 13. Nanomedicines Market Trends
    Table 14. Nanomedicines Market Drivers
    Table 15. Nanomedicines Market Challenges
    Table 16. Nanomedicines Market Restraints
    Table 17. Global Nanomedicines Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Nanomedicines Market Share by Players (2017-2022)
    Table 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2021)
    Table 20. Ranking of Global Top Nanomedicines Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Nanomedicines Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Nanomedicines Product Solution and Service
    Table 24. Date of Enter into Nanomedicines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nanomedicines Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Nanomedicines Revenue Market Share by Type (2017-2022)
    Table 28. Global Nanomedicines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Nanomedicines Revenue Market Share by Type (2023-2028)
    Table 30. Global Nanomedicines Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Nanomedicines Revenue Market Share by Application (2017-2022)
    Table 32. Global Nanomedicines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Nanomedicines Revenue Market Share by Application (2023-2028)
    Table 34. North America Nanomedicines Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Nanomedicines Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Nanomedicines Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Nanomedicines Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Nanomedicines Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Nanomedicines Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Nanomedicines Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Nanomedicines Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Nanomedicines Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Nanomedicines Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Abbott Company Detail
    Table 45. Abbott Business Overview
    Table 46. Abbott Nanomedicines Product
    Table 47. Abbott Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 48. Abbott Recent Development
    Table 49. GE Healthcare Company Detail
    Table 50. GE Healthcare Business Overview
    Table 51. GE Healthcare Nanomedicines Product
    Table 52. GE Healthcare Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 53. GE Healthcare Recent Development
    Table 54. Johnson & Johnson Company Detail
    Table 55. Johnson & Johnson Business Overview
    Table 56. Johnson & Johnson Nanomedicines Product
    Table 57. Johnson & Johnson Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 58. Johnson & Johnson Recent Development
    Table 59. Merck Company Detail
    Table 60. Merck Business Overview
    Table 61. Merck Nanomedicines Product
    Table 62. Merck Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 63. Merck Recent Development
    Table 64. Pfizer Company Detail
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Nanomedicines Product
    Table 67. Pfizer Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 68. Pfizer Recent Development
    Table 69. CombiMatrix Company Detail
    Table 70. CombiMatrix Business Overview
    Table 71. CombiMatrix Nanomedicines Product
    Table 72. CombiMatrix Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 73. CombiMatrix Recent Development
    Table 74. Celgene Company Detail
    Table 75. Celgene Business Overview
    Table 76. Celgene Nanomedicines Product
    Table 77. Celgene Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 78. Celgene Recent Development
    Table 79. Mallinckrodt Company Detail
    Table 80. Mallinckrodt Business Overview
    Table 81. Mallinckrodt Nanomedicines Product
    Table 82. Mallinckrodt Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 83. Mallinckrodt Recent Development
    Table 84. Sigma-Tau Pharmaceuticals Company Detail
    Table 85. Sigma-Tau Pharmaceuticals Business Overview
    Table 86. Sigma-Tau Pharmaceuticals Nanomedicines Product
    Table 87. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 88. Sigma-Tau Pharmaceuticals Recent Development
    Table 89. Teva Pharmaceutical Company Detail
    Table 90. Teva Pharmaceutical Business Overview
    Table 91. Teva Pharmaceutical Nanomedicines Product
    Table 92. Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 93. Teva Pharmaceutical Recent Development
    Table 94. Nanosphere Company Detail
    Table 95. Nanosphere Business Overview
    Table 96. Nanosphere NanomedicinesProduct
    Table 97. Nanosphere Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 98. Nanosphere Recent Development
    Table 99. UCB SA Company Detail
    Table 100. UCB SA Business Overview
    Table 101. UCB SA NanomedicinesProduct
    Table 102. UCB SA Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 103. UCB SA Recent Development
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanomedicines Market Share by Type: 2021 VS 2028
    Figure 2. Nanoparticles Features
    Figure 3. Nanoshells Features
    Figure 4. Nanotubes Features
    Figure 5. Nanodevices Features
    Figure 6. Others Features
    Figure 7. Global Nanomedicines Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Research Institute Case Studies
    Figure 11. Nanomedicines Report Years Considered
    Figure 12. Global Nanomedicines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Nanomedicines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nanomedicines Market Share by Region: 2021 VS 2028
    Figure 15. Global Nanomedicines Market Share by Players in 2021
    Figure 16. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2021
    Figure 18. North America Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Nanomedicines Market Share by Country (2017-2028)
    Figure 20. United States Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Nanomedicines Market Share by Country (2017-2028)
    Figure 24. Germany Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Nanomedicines Market Share by Region (2017-2028)
    Figure 32. China Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Nanomedicines Market Share by Country (2017-2028)
    Figure 40. Mexico Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Nanomedicines Market Share by Country (2017-2028)
    Figure 44. Turkey Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Nanomedicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Abbott Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 47. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 51. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 52. Celgene Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 53. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 54. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 55. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 56. Nanosphere Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 57. UCB SA Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed